Tag: Cannara Biotech Inc.

October 10, 2019

Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce

Cannara Biotech announced it has secured a mortgage against its Farnham Facility in the value of $6 million with the Canadian Imperial...
September 12, 2019

Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility

Cannara Biotech Inc. announced it has submitted to Health Canada its site evidence package for Phase One of the cultivation...
August 16, 2019

Cannara Announces Appointment of New Chief Operating Officer

Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE:LOVE, OTCQB:LOVFF, FRA:8CB), an emerging vertically integrated cannabis company focused on the...
July 30, 2019

Cannara Biotech to Webcast Live at VirtualInvestorConferences.com August 1

Cannara Biotech (CSE:LOVE, OTCQB:LOVFF), based in Montreal, Canada, is focused on the production and sale of premium cannabis and cannabis-infused products...
July 25, 2019

Cannara Biotech Inc. Reports Q3 2019 Results

Cannara Biotech ("Cannara" or the "Company") (CSE:LOVE, FRA:8CB, OTCQB:LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale...
July 12, 2019

Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares

Cannara Biotech Inc. (the "Corporation" or "Cannara") (CSE:LOVE, FRA:8CB, OTCMKTS:LOVFF), an emerging vertically integrated cannabis company focused on cultivation, and...
May 24, 2019

Cannara Biotech Appoints Dr. Sara May to its Board of Directors

Cannara Biotech Inc. (CSE:LOVE, FRA:8CB)(OTCQB:CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the...